MedPath

AZACITIDINE

These highlights do not include all the information needed to use AZACITIDINE FOR INJECTION safely and effectively. See full prescribing information for AZACITIDINE FOR INJECTION.AZACITIDINE for injection for subcutaneous or intravenous use Initial U.S. Approval: 2004

Approved
Approval ID

5c0a2d5f-8c34-4c04-8425-7543965cedd4

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jul 25, 2023

Manufacturers
FDA

Armas Pharmaceuticals Inc.

DUNS: 098405973

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

azacitidine

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code72485-201
Application NumberANDA207518
Product Classification
M
Marketing Category
C73584
G
Generic Name
azacitidine
Product Specifications
Route of AdministrationINTRAVENOUS, SUBCUTANEOUS
Effective DateDecember 22, 2020
FDA Product Classification

INGREDIENTS (2)

AZACITIDINEActive
Quantity: 100 mg in 1 1
Code: M801H13NRU
Classification: ACTIB
MANNITOLInactive
Code: 3OWL53L36A
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

AZACITIDINE - FDA Drug Approval Details